Literature DB >> 26271107

Myocardial Performance Index in Childhood Onset Essential Hypertension and White Coat Hypertension.

Monesha Gupta-Malhotra1, Rabih K Hamzeh2, Tim Poffenbarger3, Karen McNiece-Redwine4, Syed Shahrukh Hashmi5.   

Abstract

BACKGROUND: As a global measure of ventricular systolic and diastolic function, the myocardial performance index (MPI) can be an early indicator of hypertensive cardiomyopathy in children with essential hypertension (EH).
METHODS: Children with untreated newly diagnosed EH and white coat hypertension (WCH) by a 24-hour ambulatory blood pressure monitoring (ABPM), both groups without any identifiable etiology for the hypertension, were enrolled for the study. Echocardiograms and vascular ultrasounds for carotid artery intimal medial thickness were performed on all children prior to therapy. Diastolic function (peak E and A velocities, E/A ratio, isovolumic relaxation time, and deceleration times) and MPI were evaluated by simultaneous transmitral and transaortic spectral Doppler flow velocities. Systolic function was evaluated by shortening fraction and ejection fraction.
RESULTS: A cohort of 66 children (24 with EH, 42 with WCH, males 61%, median age of 13 years, range 10-17 years) were enrolled in the study. The demographic, anthropometric, laboratory tests, vascular ultrasound, and conventional echocardiographic parameters were similar between the 2 groups. There was a very small difference in MPI between the EH and WCH children (0.28 SD: 0.07 vs. 0.31 SD: 0.08, P = 0.045). However, in EH children, MPI increased by 0.14 units for every 10 unit increase in mean ABPM systolic BP (95% confidence interval: 0.03-0.25).
CONCLUSIONS: We found the increasing MPI was associated with increasing 24-hour mean systolic BP in children with EH. Therefore, MPI may have utility as a single, quick, noninvasive method of detection and tracking of subclinical hypertensive heart disease. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Tei index.; blood pressure; carotid intimal medial thickness; diastolic function; echocardiogram; hypertension; left ventricular hypertrophy; systolic function

Mesh:

Year:  2015        PMID: 26271107      PMCID: PMC5006440          DOI: 10.1093/ajh/hpv123

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  47 in total

1.  Correlation of the Tei index with invasive measurements of ventricular function in a porcine model.

Authors:  Jared C LaCorte; Santos E Cabreriza; David G Rabkin; Beth F Printz; Lindita Coku; Alan Weinberg; Welton M Gersony; Henry M Spotnitz
Journal:  J Am Soc Echocardiogr       Date:  2003-05       Impact factor: 5.251

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements.

Authors:  C Tei; R A Nishimura; J B Seward; A J Tajik
Journal:  J Am Soc Echocardiogr       Date:  1997-03       Impact factor: 5.251

4.  Aortic dilatation in children with systemic hypertension.

Authors:  Monesha Gupta-Malhotra; Richard B Devereux; Archana Dave; Cynthia Bell; Ronald Portman; Diana Milewicz
Journal:  J Am Soc Hypertens       Date:  2014-01-09

5.  Modified TEI index: a promising parameter in essential hypertension?

Authors:  Nurgül Keser; Sezai Yildiz; Nuri Kurtoğ; Ismet Dindar
Journal:  Echocardiography       Date:  2005-04       Impact factor: 1.724

Review 6.  White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis.

Authors:  Cesare Cuspidi; Marta Rescaldani; Marijana Tadic; Carla Sala; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

7.  Left ventricular function impairment in pregnancy-induced hypertension.

Authors:  M Vázquez Blanco; J Roisinblit; O Grosso; G Rodriguez; S Robert; C S Berensztein; H R Vega; J Lerman
Journal:  Am J Hypertens       Date:  2001-03       Impact factor: 2.689

8.  Myocardial global performance index as a predictor of in-hospital cardiac events in patients with first myocardial infarction.

Authors:  Luigi Ascione; Mario De Michele; Maria Accadia; Salvatore Rumolo; Lucia Damiano; Antonello D'Andrea; Pasquale Guarini; Bernardino Tuccillo
Journal:  J Am Soc Echocardiogr       Date:  2003-10       Impact factor: 5.251

9.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

10.  Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy.

Authors:  W H Gaasch; M R Zile; P K Hoshino; C S Apstein; A S Blaustein
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

View more
  4 in total

Review 1.  Ambulatory Blood Pressure Monitoring in Pediatrics.

Authors:  Sonali S Patel; Stephen R Daniels
Journal:  Curr Hypertens Rep       Date:  2019-07-26       Impact factor: 5.369

2.  Correlation between serum miR-122 and myocardial damage and ventricular function in patients with essential hypertension.

Authors:  Liangguo Wang; Huabing Chen
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 3.005

Review 3.  Ambulatory Blood Pressure Monitoring in Children and Adolescents: a Review of Recent Literature and New Guidelines.

Authors:  Ian Macumber
Journal:  Curr Hypertens Rep       Date:  2017-10-25       Impact factor: 5.369

4.  Epidemiology of Childhood Onset Essential Hypertension.

Authors:  Monesha Gupta-Malhotra; Sanjay Shete; Michelle S Barratt; Dianna Milewicz; Syed Shahrukh Hashmi
Journal:  J Hum Hypertens       Date:  2018-09-17       Impact factor: 3.012

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.